Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Canadian Securities Exchange
10:24:58 2021-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| 08-11 | BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | BioHarvest Sciences Inc. Revises Consolidated Earnings Guidance for the Fiscal Year 2026 | CI |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 41.94 | - | - |
| Change | - | 41.36% | 9.8% | -64.33% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 41.94 | 41.94 | 41.94 |
| Change | - | 41.36% | 9.8% | -64.33% | 0% | 0% |
| P/E | -5.28x | -7.73x | -8.65x | -3.51x | -5.52x | 14.2x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.3x | 0.2x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 1.12x | 0.85x | 0.59x |
| EV / Revenue | - | 0x | 0x | 1.12x | 0.85x | 0.59x |
| EV / EBITDA | - | -0x | -0x | -5.5x | -11.5x | 8.76x |
| EV / EBIT | - | -0x | -0x | -4.67x | -8.61x | 7.55x |
| EV / FCF | - | -0x | -0x | -3.55x | -3.18x | 9.79x |
| FCF Yield | - | -8.89% | -8.15% | -28.1% | -31.4% | 10.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.5275 | -0.335 | 0.13 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 37.42 | 49.59 | 71.53 |
| EBITDA 1 | - | -5.738 | -3.951 | -7.618 | -3.641 | 4.786 |
| EBIT 1 | - | -6.989 | -5.575 | -8.977 | -4.87 | 5.555 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -12.02 | -7.648 | 3.409 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 1.850 | 1.850 | 1.850 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 4/30/24 | 3/31/25 | 3/31/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.2x | 1.93x | 13.04x | 5.54% | 13.4B | |
| 25.75x | 1.44x | 9.53x | 2.12% | 4.78B | |
| 15.15x | 3.06x | 9.39x | 6.53% | 4.36B | |
| 16.88x | - | - | 1.38% | 3.78B | |
| 25.77x | - | - | - | 3.43B | |
| 15.69x | 2.25x | 9.42x | 2.77% | 3.12B | |
| Average | 19.24x | 2.17x | 10.35x | 3.67% | 5.48B | |
| Weighted average by Cap. | 18.48x | 2.07x | 11.33x | 4.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
